Semaglutide is a glucagon-like peptide-1 agonist that works on the GLP-1 receptors in the body to reduce appetite by delaying gastric emptying
Maybe you could comment about that
Skovbjerg G, Roostalu U, Salinas CG, Skytte JL, Perens J, Clemmensen C, et al
mean age: 66.9 years), 25,533 pairs of SGLT2i versus DPP4i initiators (cohort entry: 20132022
The result: Reduced appetite You feel genuinely satisfied with less food, not deprived Fewer cravings The constant mental chatter about food quiets down Slower digestion Food stays in your stomach longer, keeping you full between meals Better blood sugar control Fewer energy crashes and hunger spikes throughout the day Cardiovascular benefits Research shows reduced risk of heart attacks and strokes in people taking GLP-1 medications This isnt willpower in a syringe